The interface of atherosclerosis and thrombosis: Basic mechanisms

Vascular Medicine

Volumn 3, Issue 3, 1998, Pages 225-229

  Libby, Peter ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Atherosclerosis; Inflammation; Macrophage; Metalloproteinase; Smooth muscle cell; Thrombosis

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; GAMMA INTERFERON; INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA;

ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD CLOTTING; CONFERENCE PAPER; ENZYME RELEASE; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; MACROPHAGE; PRIORITY JOURNAL; THROMBOGENESIS; THROMBOSIS; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

EID: 0031774870     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358836X9800300309     Document Type: Conference Paper

References (57)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020. Global Burden of Disease Study. Lancet 1997, 349: 1498-504
2. Hajjar DP, Haberland ME. Lipoprotein trafficking in vascular cells. Molecular Trojan horses and cellular saboteurs. J Biol Chem 1997; 272: 22 975-78.
3. Kozarsky KF, Donahee MH, Rigotti A, Iqbal SN, Edelman ER, Krieger M. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 1997; 387: 414-17
4. Heinrich J, Schulte H, Schonfeld R, Kohler E, Assmann G Association of variables of coagulation, fibrinolysis, and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost 1995; 73 374-379.
5. Mach F, Schoenbeck U, Sukhova GK et al Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis Proc Natl Acad Sci U S A 1997; 94: 1931-36
6. Gupta S, Pablo AM, Jiang XC et al. Interferon-gamma potentiates atherosclerosis in ApoE knock-out mice J Clin Invest 1997; 99: 2752-61.
7. Jeziorska M, McCollum C, Woolley DE. Mast cell distribution, activation, and phenotype in atherosclerotic lesions of human carotid arteries. J Pathol 1997; 182: 115-22.
8. Atkinson JB, Harlan CW, Harlanm GC, Virmani R. The association of mast cells and atherosclerosis: a morphologic study of early atherosclerotic lesions in young people Hum Pathol 1994; 25: 154-59
9. Kaartinen M, Penttila A, Kovanen PT. Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha. Circulation 1996; 94: 2787-92
10. Kaartinen M, Penttila A, Kovanen PT Mast cells accompany microvessels in human coronary atheromas: implications for intimal neovascularization and hemorrhage. Atherosclerosis 1996; 123: 123-31.
11. Lindstedt L, Lee M, Castro GR, Fruchart JC, Kovanen PT. Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid. J Clin Invest 1996; 97: 2174-2182.
12. Miller J, Knorr R, Ferrone M, Houdei R, Carron CP, Dustin ML. Intercellular adhesion molecule-1 dimerization and its consequences for adhesion mediated by lymphocyte function associated-1 J Exp Med 1995; 182: 1231-41.
13. Printseva OY, Peclo MM, Gown AM. Various cell types in human atherosclerotic lesions express ICAM-1. Further immunocytochemical and immunochemical studies employing monoclonal antibody 10F3. Am J Pathol 1992; 140(4): 889-96
14. Vlassara H, Fuh H, Donnelly T, Cybulsky M. Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Mol Med 1995; 1(4): 447-56.
15. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis Science 1991; 251: 733-91
16. Norman KE, Moore KL, McEver RP, Ley K. Leukocyte rolling in vivo is mediated by P-selectin glycoprotein ligand-1. Blood 1995; 86(12): 4417-21.
17. Lorant DE, Zimmerman GA, McIntyre TM, Prescott SM Platelet-activating factor mediates procoagulant activity on the surface of endothelial cells by promoting leukocyte adhesion Semin Cell Biol 1995; 6(5): 295-303.
18. Li H, Cybulsky MI, Gimbrone MA Jr, Libby P. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb 1993; 13: 197-204.
19. Poston RN, Haskard DO, Coucher JR, Gall NP, Johnson-Tidey RR Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 1992; 140(3): 665-73.
20. Poston RN, Johnson-Tidey RR. Localized adhesion of monocytes to human atherosclerotic plaques demonstrated in vitro: implications for atherogenesis. Am J Pathol 1996; 149: 73-80
21. Davies MJ, Gordon JL, Gearing AJ et al The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 1993; 171: 223-29.
22. Vora DK, Fang ZT, Liva SM et al. Induction of P-selectin by oxidized lipoproteins. Separate effects on synthesis and surface expression. Circ Res 1997; 80(6): 810-18
23. Kodama T, Reddy P, Kishimoto C, Krieger M. Purification and characterization of a bovine acetyl low density lipoprotein receptor. Proc. Natl Acad Sci U S A 1988; 85(23): 9238-42.
24. Ramprasad MP, Fischer W, Witztum JL, Sambrano GR, Quehenberger O, Steinberg D. The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci U S A 1995; 92: 9580-84.
25. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. CD36 is a receptor for oxidized low-density lipoprotein. J Biol Chem 1993; 268: 11 811-16.
26. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996; 271: 518-20
27. van den Eijnden MM, Steenhauer SI, Reitsma PH, Bertina RM. Tissue factor expression during monocyte-macrophage differentiation. Thromb Haemost 1997; 77: 1129-36.
28. Auwerx JH, Deeb S, Brunzell JD, Peng R, Chait A. Transcriptional activation of the lipoprotein lipase and apolipoprotein E genes accompanies differentiation in some human macrophage-like cell lines. Biochemistry 1988; 27: 2651-55.
29. Elstad MR, Stafforini DM, McIntyre TM, Prescott SM, Zimmerman GA. Platelet-activating factor acetylhydrolase increases during macrophage differentiation. A novel mechanism that regulates accumulation of platelet-activating factor J Biol Chem 1989; 264: 8467-70.
30. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-43.
31. Moreno PR, Bernardi VH, Lopez-Cuellar J et al. Macrophages, smooth muscle cells and tissue factor in unstable angina, implications for cell mediated thrombogenicity in acute coronary syndromes. Circulation 1996; 94: 3090-97.
32. Edwards RL, Rickles FR. The role of human T cells (and T cell products) for monocyte tissue factor generation. J Immunol 1980; 125(2): 606-609.
33. Mach F, Schonbeck U, Bonnefoy JY, Pober JS, Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40, induction of collagenase, stromelysm, and tissue factor. Circulation 1997; 96: 396-99
34. Dentan C, Lesnik P, Chapman MJ, Ninio E. Phagocytic activation induces formation of platelet-activating factor in human monocyte-derived macrophages and in macrophage-derived foam cells. Relevance to the inflammatory reaction in atherogenesis. Eur J Biochem 1996; 236: 48-55
35. Geng Y-J, Libby P. Evidence for apoptosis in advanced human atheroma. Co-localization with interleukin-1beta-converting enzyme Am J Pathol 1995; 147: 251-66.
36. Geng YJ, Wu Q, Muszynski M, Hansson GK, Libby P Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta Arterioscler Thromb Vasc Biol 1996; 16: 19-27.
37. Lee R, Libby P. The unstable atheroma Arterioscler Thromb Vasc Biol 1997; 17(10): 1859-67.
38. Davies MJ. Stability and instability two faces of coronary atherosclerosis. The Paul Dudley White Lecture. Circulation 1995, 94(8): 2013-19.
39. Felton CV, Crook D, Davies MJ, Oliver MF. Relation of plaque lipid composition and morphology to the stability of human aortic plaques. Arterioscler Thromb Vasc Biol 1997; 17(7): 1337-45.
40. Libby P, Geng YJ, Aikawa M et al. Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol 1996; 7(5): 330-35.
41. Galis ZS, Sukhova GK, Kranzhofer R, Clark S, Libby P Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases Proc Natl Acad Sci U S A 1995; 92(2): 402-406.
42. Saren P, Welgus HG, Kovanen PT. TNF-α and IL-1 selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 1996; 157(9) 4159-65.
43. Lacraz S, Nicod LP, Chichepoitiche R, Welgus HG, Dayer JM. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invent 1995; 96(5): 2304-10.
44. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Libby P. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic plaque. Ann N Y Acad Sci 1995; 748: 501-507.
45. Schoenbeck U, Mach F, Sukhova GK et al Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes a role for CD40 signaling in plaque rupture? Circ Res 1997; 81 448-54
46. Malik N, Greenfield BW, Wahl AF, Kiener PA. Activation of human monocytes through CD40 induces matrix metalloproteinases. J Immunol 1996; 156: 3952-60.
47. Carmeliet P, Moons L, Lijnen R et al Uiokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet 1997; 17(4): 439-44.
48. Galis ZS, Kranzhofer R, Fenton JW, Libby P. Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells. Anerioscler Thromb Vasc Biol 1997; 17: 483-89
49. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro Implications for atherosclerotic plaque stability J Clin Invest 1996; 98: 2572-79.
50. Amento EP, Ehsani N, Palmer H, Libby P. Cytokines positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arteriosclerosis 1991; 11 1223-30.
51. Halloran BG, Grange JJ, So BJ, Baxter BT. Macrophage products inhibit human aortic smooth muscle cell proliferation and alter I alpha (I) procollagen expression. Ann Vasc Surg 1997; 11 80-84.
52. Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF Science 1991; 253: 1129-32.
53. Webb DJ, Hussaini IM, Weaver AM et al Activated alpha 2-macroglobulin promotes mitogenesis in rat vascular smooth muscle cells by a mechanism that is independent of growth-factor-carrier activity. Eur J Biochem 1995; 234: 714-22.
54. Warner TD Influence of endothelial mediators on the vascular smooth muscle and circulating platelets and blood cells. Int Angiol 1996; 15(2): 93-99.
55. Fukuo K, Nakahashi T, Nomura S et al Possible participation of Fas-mediated apoptosis in the mechanism of atherosclerosis Gerontology 1997; 43(suppl) 35-42.
56. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 1995; 95: 2266-74.
57. Toschi V, Gallo R, Lettino M et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 1997; 95(3): 594-99.